Results 101 to 110 of about 3,499 (203)

Hyper-reactive malarial splenomegaly and splenic infarct in a caucasian toddler

open access: yesInfectious Disease Reports, 2011
A 4-year-old boy from the United States had been staying in Indonesia for five months when he presented with fever, severe lethargy, progressive weight loss, and abdominal distension.
Anselm Chi-Wai Lee
doaj   +1 more source

Atovaquone/Proguanil Resistance in an Imported Malaria Case in Chile. [PDF]

open access: yesAm J Trop Med Hyg, 2021
Chenet SM   +8 more
europepmc   +1 more source

Unanticipated CNS Safety Signal in a Placebo-Controlled, Randomized Trial of Co-Administered Atovaquone-Proguanil and Amodiaquine. [PDF]

open access: yesClin Pharmacol Ther, 2022
Chalon S   +7 more
europepmc   +1 more source

Plant-derived antimalarial agents: from crude extracts to isolated bioactive compounds [PDF]

open access: yes, 2011
Despite decades of intense research, malaria remains a deadly disease of the developing worlds. Drugresistance to limited available antimalarials, in part, has contributed to the persistence of this infectious disease.
Abdullah, Wan Omar, Ismail, Patimah
core  

Selection of Cytochrome b Mutants Is Rare among Plasmodium falciparum Patients Failing Treatment with Atovaquone-Proguanil in Cambodia. [PDF]

open access: yesAntimicrob Agents Chemother, 2021
Lin JT   +15 more
europepmc   +1 more source

Travellers’ adherence to atovaquone/proguanil malaria chemoprophylaxis after return from endemic areas

open access: yesTravel Medicine and Infectious Disease
Background: According to current guidelines, atovaquone/proguanil (AP) malaria chemoprophylaxis is taken once daily during travel, and continued for seven days after return from malaria-endemic areas.
Jenny Lea Schnyder   +5 more
doaj   +1 more source

False-Positive Malaria Rapid Diagnostic Test Likely Due to African Tick Bite Fever: A Case Report

open access: yesReports
Background and Clinical Significance: Fever in the returning traveler is a medical emergency warranting prompt exclusion of potentially life-threatening infections such as malaria.
Rahel T. Zewude   +3 more
doaj   +1 more source

Medicines for the prevention of malaria while traveling - Atovaquone-proguanil (Malarone\u2122) [PDF]

open access: yes
Atovaquone-proguanil is a combination of two drugs, atovaquone and proguanil, in a single tablet. It is available in the United States by prescription only.

core  

When should travelers begin malaria prophylaxis? [PDF]

open access: yes, 2007
Travelers should start on chloroquine 1 to 2 weeks before entering an area without chloroquine resistance (strength of recommendation [SOR]: C, based on expert opinion).
Clark, Steven L.   +2 more
core  

Assessment of acceptability and ease of use of atovaquone/proguanil medication in subjects undergoing malaria prophylaxis

open access: yesTherapeutics and Clinical Risk Management, 2008
V Nicosia1, Giorgio Colombo2, M Consentino1, S Di Matteo2, F Mika1, S De Sanctis1, S Ratti2, Marta Vinci21Saipem Medical Dept. San Donato Milanese, Italy; 2S.A.V.E.
V Nicosia   +5 more
doaj  

Home - About - Disclaimer - Privacy